Please enable Javascript to use all features and improve your user experience.
DGM 2023
Programme
People
Search
DE
All people
Marko Kokic
Cambridge / US
Amylyx Pharmaceuticals, Inc.
Sort by Type
Date
Speaker
22/03/2023
Poster
P 97
Long-Term Benefits in Overall Survival, Function, and Safety With a Fixed-Dose Combination of Sodium Phenylbutyrate and Ursodoxicoltaurine (AMX0035) in Amyotrophic Lateral Sclerosis
Biomarker - molekular, klinisch, digital, Therapie
Further involvements
22/03/2023
Poster
P 97
Long-Term Benefits in Overall Survival, Function, and Safety With a Fixed-Dose Combination of Sodium Phenylbutyrate and Ursodoxicoltaurine (AMX0035) in Amyotrophic Lateral Sclerosis
Biomarker - molekular, klinisch, digital, Therapie
© Conventus Congressmanagement & Marketing GmbH
Imprint
Privacy